COVID-19專家諮詢會參照最新實證與藥物適應症，更新治療指引藥物適用對象並重申制定原則(疾病管制署致醫界通函第467號)
https://www.cdc.gov.tw/Bulletin/Detail/1pVYYgWzE_U3RlTuctsioQ?typeid=48
NX mark this message contains misinformation
｜originally written by NX
假訊息，伊維菌素非WHO及權威機構認可治療新冠肺炎(COVID-19)藥物，請民眾勿信勿傳。
References
一、https://www.cdc.gov.tw/Bulletin/Detail/1pVYYgWzE_U3RlTuctsioQ?typeid=48 (衛福部)二、https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials (WHO)
三、https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 (FDA)
Cannot get data from URL
Cannot get data from URL
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.